Molecular heterogeneity and immunosuppressive microenvironment in glioblastoma

S DeCordova, A Shastri, AG Tsolaki, H Yasmin… - Frontiers in …, 2020 - frontiersin.org
Glioblastoma (GBM) is the most aggressive primary brain tumor in adults, with a poor
prognosis, despite surgical resection combined with radio-and chemotherapy. The major …

Current and future trends on diagnosis and prognosis of glioblastoma: from molecular biology to proteomics

AS Silantyev, L Falzone, M Libra, OI Gurina… - Cells, 2019 - mdpi.com
Glioblastoma multiforme is the most aggressive malignant tumor of the central nervous
system. Due to the absence of effective pharmacological and surgical treatments, the …

Targeting glucose metabolism of cancer cells with dichloroacetate to radiosensitize high-grade gliomas

KM Cook, H Shen, KJ McKelvey, HE Gee… - International Journal of …, 2021 - mdpi.com
As the cornerstone of high-grade glioma (HGG) treatment, radiotherapy temporarily controls
tumor cells via inducing oxidative stress and subsequent DNA breaks. However, almost all …

MiR-144: a new possible therapeutic target and diagnostic/prognostic tool in cancers

O Kooshkaki, Z Rezaei, M Rahmati, P Vahedi… - International journal of …, 2020 - mdpi.com
MicroRNAs (miRNAs) are small and non-coding RNAs that display aberrant expression in
the tissue and plasma of cancer patients when tested in comparison to healthy individuals …

miRNA signature in glioblastoma: Potential biomarkers and therapeutic targets

O Rezaei, K Honarmand, S Nateghinia, M Taheri… - Experimental and …, 2020 - Elsevier
MicroRNAs (miRNAs) are transcripts with sizes of about 22 nucleotides, which are produced
through a multistep process in the nucleus and cytoplasm. These transcripts modulate the …

[HTML][HTML] MicroRNAs in adult high-grade gliomas: Mechanisms of chemotherapeutic resistance and their clinical relevance

Y Jegathesan, PP Stephen, ISEE Sati… - Biomedicine & …, 2024 - Elsevier
Notorious for its high mortality rate, the current standard treatment for high-grade gliomas
remains a challenge. This is largely due to the complex heterogeneity of the tumour coupled …

Plasma exosomal miRNA expression profile as oxaliplatin-based chemoresistant biomarkers in colorectal adenocarcinoma

J Han, W Sun, R Liu, Z Zhou, H Zhang, X Chen… - Frontiers in …, 2020 - frontiersin.org
Background: Chemotherapy is one of the most common therapies used in the treatment of
colorectal cancer (CRC), but chemoresistance inevitably occurs. It is challenging to obtain …

Comparison of oncogenes, tumor suppressors, and MicroRNAs between schizophrenia and glioma: the balance of power

JS Brown Jr - Neuroscience & Biobehavioral Reviews, 2023 - Elsevier
The risk of cancer in schizophrenia has been controversial. Confounders of the issue are
cigarette smoking in schizophrenia, and antiproliferative effects of antipsychotic medications …

Targeting glioblastoma: The current state of different therapeutic approaches

I Khan, S Mahfooz, EB Elbasan… - Current …, 2021 - benthamdirect.com
Background: Glioma is the primary cancer of the central nervous system in adults. Among
gliomas, glioblastoma is the most deadly and aggressive form, with an average life span of 1 …

[HTML][HTML] MicroRNA-144: a novel biological marker and potential therapeutic target in human solid cancers

M Zhou, Y Wu, H Li, X Zha - Journal of Cancer, 2020 - ncbi.nlm.nih.gov
MicroRNAs (miRNAs) are a class of small non-coding RNAs that negatively regulate gene
expression at the post-transcriptional level. It has been reported that microRNA-144 (miR …